Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 102, Issue 12 , Pages 1171-1175 , December 2008

Controversies in the Helicobacter pylori/duodenal ulcer story

  • Michael Hobsley

      Affiliations

    • Department of Surgery, Royal Free and University College London Medical School, University College London, London, UK
    • Corresponding Author InformationCorresponding author. Present address: Fieldside, Barnet Lane, Totteridge, London N20 8AS, UK. Tel.: +44 20 8445 6507.
    • ,
  • Frank I. Tovey

      Affiliations

    • Department of Surgery, Royal Free and University College London Medical School, University College London, London, UK
    • ,
  • John Holton

      Affiliations

    • Centre for Infectious Diseases and International Health, Royal Free and University College London Medical School, University College London, London, UK

Received 21 April 2008 ,Revised 24 April 2008 ,Accepted 24 April 2008.

References 

  1. Baron JH. Peptic ulcer. Mt Sinai J. Med. 2000;67:58–62
  2. Baron JH, Sonnenberg A. Hospital admissions for peptic ulcer and indigestion in London and New York in the 19th and early 20th centuries. Gut. 2001;50:568–570
  3. Baron JH, Sonnenberg A. Alimentary diseases in the poor and middle class in London 1773–1815, and in New York poor 1797–1818. Aliment. Pharmacol. Ther. 2002;16:1709–1714
  4. Borody TJ, George LL, Brandl S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am. J. Gastroenterol. 1991;86:1154–1157
  5. Boulos PB, Botha A, Hobsley M, Holton J, Oshowo AO, Tovey FI. Possible absence of Helicobacter pylori in the early stages of duodenal ulceration. QJM. 2002;95:749–752
  6. Bytzer P, Teglbjaerg PS. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis—results from a randomized trial with 2-year follow-up. Am. J. Gastroenterol. 2001;96:1409–1416
  7. Bytzer P, Aalykke C, Rune S, Weywadt L, Gjorup T, Eriksen J, et al. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand. J. Gastroenterol. 2000;35:1023–1032
  8. Chandrakumaran K, Vaira D, Hobsley M. Duodenal ulcer, Helicobacter pylori, and gastric secretion. Gut. 1994;35:1033–1036
  9. Ching CK, Lam SK. Helicobacter pylori epidemiology in relation to peptic ulcer and gastric cancer in south and north China. J. Gastroenterol. Hepatol. 1994;9(Suppl. 1):S4–S7
  10. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am. J. Gastroenterol. 1999;94:1834–1840
  11. Clyne M, Labigne A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect. Immun. 1995;63:1669–1673
  12. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, et al. Traces of human migrations in Helicobacter pylori populations. Science. 2003;299:1582–1585
  13. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ. Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow-up. Lancet. 1994;343:258–260
  14. Hobsley M, Tovey FI. Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection? World J. Gastroenterol. 2001;7:149–151
  15. Hobsley M, Whitfield PF. The likelihood of a disease in relation to the magnitude of a risk factor. The example of duodenal ulcer. Theor. Surg. 1987;2:6–9
  16. Hobsley M, Tovey FI, Holton J. Precise role of H. pylori in duodenal ulceration. World J. Gastroenterol. 2006;12:6413–6419
  17. Hobsley M, Tovey FI, Holton J. How labile is gastric infection with H. pylori?. World J. Gastroenterol. 2007;13:4665–4668
  18. Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33:429–431
  19. Huang WH, Wang HH, Wu WW, Lai HC, Hsu CH, Cheng KS. Helicobacter pylori infection in patients with ulcer recurrence after partial gastrectomy. Hepatogastroenterology. 2004;51:1551–1553
  20. Jayaraj AP, Tovey FI, Clark CG. Possible dietary protective factors in relation to the distribution of duodenal ulcer in India and Bangladesh. Gut. 1980;21:1068–1076
  21. Jayaraj AP, Tovey FI, Lewin MR, Clark CG. Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids. J. Gastroenterol. Hepatol. 2000;15:610–616
  22. Jayaraj AP, Tovey FI, Hobsley M. Duodenal ulcer prevalence: research into the nature of possible protective dietary lipids. Phytother. Res. 2003;17:391–398
  23. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?. Am. J. Gastroenterol. 1998;93:574–578
  24. Kidd M, Modlin IM. A century of Helicobacter pylori. Digestion. 1998;59:1–15
  25. Laine L, Hopkins RJ, Girardi S. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been exaggerated? A meta-analysis of rigorously designed trials. Am. J. Gastroenterol. 1998;93:1409–1415
  26. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007;445:415–419
  27. Marshall BJ, Armstrong BJ, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med. J. Aust. 1985;142:436–439
  28. Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology. 1990;99:697–702
  29. Martin IG, Diament RH, Dixon MF, Axon AT, Johnston D. Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur. J. Gastroenterol. Hepatol. 1995;7:207–209
  30. Martino G, Paoletti M, Marcheggiano A, D’Ambra G, Delle Fave G, Annibale B. Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study. Helicobacter. 1999;4:213–217
  31. Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter. 2004;9:9–16
  32. Pearce HR, Kalia N, Bardhan KD, Atherton JC, Brown NJ. Effects of Helicobacter pylori on endothelial cell proliferation and chemotaxis. Digestion. 2004;69:201–210
  33. Pest P, Zarate J, Varsky C, Man F, Schraier M. Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer. Acta Gastroenterol. Latinoam. 1996;26:273–276
  34. Prach AT, Malek M, Tavakoli M, Hopwood D, Senior BW, Murray FE. H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Aliment. Pharmacol. Ther. 1998;12:873–880
  35. Roxburgh JC, Whitfield PF, Hobsley M. Effect of acute cigarette smoking on gastric secretion. Gut. 1992;33:1170–1173
  36. Schwarz K. Ueber penetrierende magen- und jejunal geshwure. Beitr. Klin. Chir. 1910;67:96–128
  37. Segal I, Ally R, Sitas F, Walker AR. Co-screening for primary biliary cirrhosis and coeliac disease. Helicobacter pylori: the African enigma. Gut. 1998;43:300–301
  38. Segal I, Ally R, Mitchell H. Helicobacter pylori—an African perspective. QJM. 2001;94:561–565
  39. Sjostrom JF, Larsson H. Factors affecting growth and antibiotic sensitivity of Helicobacter pylori: effects of pH and urea on survival of a wild-type strain and a urease-deficient mutant. J. Med. Microbiol. 1996;44:425–433
  40. Tabel G, Hoa NT, Tarnawski A, Chen J, Domek M, Ma TY. Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro. J. Lab. Clin. Med. 2003;142:421–430
  41. Tovey FI. Duodenal ulcer in China. J. Gastroenterol. Hepatol. 1992;7:427–431
  42. Tovey FI. Diet and duodenal ulceration. J. Gastroenterol. Hepatol. 1994;9:177–185
  43. Tovey FI, Tunstall M. Duodenal ulcer in black populations in Africa south of the Sahara. Gut. 1975;16:564–576
  44. Tovey FI, Jayaraj AP, Lewin MR, Clark CG. Diet: its role in the genesis of peptic ulceration. Dig. Dis. 1989;7:309–323
  45. Tovey FI, Hobsley M, Kaushik SP, Pandey R, Kurian G, Singh K, et al. Duodenal gastric metaplasia and Helicobacter pylori infection in high and low duodenal ulcer-prevalent areas in India. J. Gastroenterol. Hepatol. 2004;19:497–505
  46. Tovey FI, Hobsley M, Segal I, Jayaraj AP. Duodenal ulcer in South Africa: home-pounded versus milled maize. J. Gastroenterol. Hepatol. 2005;20:1008–1011
  47. Tovey FI, Hobsley M, Holton J. Helicobacter pylori virulence factors in duodenal ulceration: a primary cause or a secondary infection causing chronicity. World J. Gastroenterol. 2006;12:6–9
  48. Whitfield PF, Hobsley M. A standardised technique for the performance of accurate gastric secretion studies. Agents Actions. 1979;9:327–332
  49. Whitfield PF, Hobsley M. Comparison of maximal gastric secretion in smokers and non-smokers with and without duodenal ulcer. Gut. 1987;28:557–560
  50. Wong BC, Ching CK, Lam SK, Li ZL, Chen BW, Li YN, et al. Differential north to south gastric cancer–duodenal ulcer gradient in China. China Ulcer Study Group. J. Gastroenterol. Hepatol. 1998;13:1050–1057
  51. Yamaoka Y, Osato MS, Seoukveda AR, Gutierrez O, Figura N, Kim JG, et al. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol. Infect. 2000;124:91–96
  52. Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saiton N, Kodama T, et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 2002;517:180–184

PII: S0035-9203(08)00206-X

doi: 10.1016/j.trstmh.2008.04.035

Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 102, Issue 12 , Pages 1171-1175 , December 2008

Article Tools